197 related articles for article (PubMed ID: 10607312)
1. Functional definition of a B cell epitope, KGEQGEPGA, on C1q the Fc-binding subunit of the first component of complement.
Trinder PK; Märker-Hermann E; Loos M; Maeurer MJ
Scand J Immunol; 1999 Dec; 50(6):635-41. PubMed ID: 10607312
[TBL] [Abstract][Full Text] [Related]
2. C1q A08 Is a Half-Cryptic Epitope of Anti-C1q A08 Antibodies in Lupus Nephritis and Important for the Activation of Complement Classical Pathway.
Wu WJ; Tan Y; Liu XL; Yu F; Zhao MH
Front Immunol; 2020; 11():848. PubMed ID: 32536911
[TBL] [Abstract][Full Text] [Related]
3. The collagen-like component of the complement system, C1q, is recognized by 7 S autoantibodies and is functionally impaired in synovial fluids of patients with rheumatoid arthritis.
Trinder PK; Maeurer MJ; Brackertz D; Loos M
Immunology; 1996 Mar; 87(3):355-61. PubMed ID: 8778019
[TBL] [Abstract][Full Text] [Related]
4. C1q as antigen in humoral autoimmune responses.
Siegert CE; Daha MR
Immunobiology; 1998 Aug; 199(2):295-302. PubMed ID: 9777413
[TBL] [Abstract][Full Text] [Related]
5. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse.
Burkhardt H; Koller T; Engström A; Nandakumar KS; Turnay J; Kraetsch HG; Kalden JR; Holmdahl R
Arthritis Rheum; 2002 Sep; 46(9):2339-48. PubMed ID: 12355481
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to the collagen-like region of C1q and type II collagen are independent non-cross-reactive populations in systemic lupus erythematosus and rheumatoid arthritis.
Cook AD; Rowley MJ; Wines BD; Mackay IR
J Autoimmun; 1994 Jun; 7(3):369-78. PubMed ID: 7522456
[TBL] [Abstract][Full Text] [Related]
7. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay.
Vanhecke D; Roumenina LT; Wan H; Osthoff M; Schaller M; Trendelenburg M
Arthritis Rheum; 2012 Nov; 64(11):3706-14. PubMed ID: 22740328
[TBL] [Abstract][Full Text] [Related]
8. Natural human antibodies to synthetic peptide autoantigens: correlations with age and autoimmune disease.
Marchalonis JJ; Schluter SF; Wilson L; Yocum DE; Boyer JT; Kay MM
Gerontology; 1993; 39(2):65-79. PubMed ID: 8514202
[TBL] [Abstract][Full Text] [Related]
9. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.
Thanei S; Vanhecke D; Trendelenburg M
Clin Immunol; 2015 Oct; 160(2):180-7. PubMed ID: 26148903
[TBL] [Abstract][Full Text] [Related]
10. Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus Erythematosus.
Kleer JS; Rabatscher PA; Weiss J; Leonardi J; Vogt SB; Kieninger-Gräfitsch A; Chizzolini C; Huynh-Do U; Ribi C; Trendelenburg M
Front Immunol; 2021; 12():761395. PubMed ID: 35087514
[TBL] [Abstract][Full Text] [Related]
11. Modulation of type II collagen-induced arthritis in DBA/1 mice by intravenous application of a peptide from the C1q-A chain.
Maeurer MJ; Trinder PK; Störkel S; Loos M
Immunobiology; 1992 Jun; 185(1):103-20. PubMed ID: 1398737
[TBL] [Abstract][Full Text] [Related]
12. Autoreactivity to mouse C1q in a murine model of SLE.
Trinder PK; Maeurer MJ; Schorlemmer HU; Loos M
Rheumatol Int; 1995; 15(3):117-20. PubMed ID: 8588121
[TBL] [Abstract][Full Text] [Related]
13. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
Antes U; Heinz HP; Loos M
J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
[TBL] [Abstract][Full Text] [Related]
14. C1q in autoimmune diseases: rheumatoid arthritis.
Maeurer MJ; Trinder PK; Störkel S; Loos M
Behring Inst Mitt; 1993 Dec; (93):262-78. PubMed ID: 8172576
[TBL] [Abstract][Full Text] [Related]
15. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus.
Wisnieski JJ; Jones SM
J Immunol; 1992 Mar; 148(5):1396-403. PubMed ID: 1538123
[TBL] [Abstract][Full Text] [Related]
16. Immunization with an apoptotic cell-binding protein recapitulates the nephritis and sequential autoantibody emergence of systemic lupus erythematosus.
Levine JS; Subang R; Nasr SH; Fournier S; Lajoie G; Wither J; Rauch J
J Immunol; 2006 Nov; 177(9):6504-16. PubMed ID: 17056583
[TBL] [Abstract][Full Text] [Related]
17. Antigen localization within the splenic marginal zone restores humoral immune response and IgG class switch in complement C4-deficient mice.
Zachrau B; Finke D; Kropf K; Gosink HJ; Kirchner H; Goerg S
Int Immunol; 2004 Dec; 16(12):1685-90. PubMed ID: 15477230
[TBL] [Abstract][Full Text] [Related]
18. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.
Nielsen CT; Østergaard O; Stener L; Iversen LV; Truedsson L; Gullstrand B; Jacobsen S; Heegaard NH
Arthritis Rheum; 2012 Apr; 64(4):1227-36. PubMed ID: 22238051
[TBL] [Abstract][Full Text] [Related]
19. IgG autoantibodies to C1q do not detectably influence complement activation in vivo and in vitro in systemic lupus erythematosus.
Siegert CE; Daha MR; Lobatto S; van der Voort EA; Breedveld FC
Immunol Res; 1992; 11(2):91-7. PubMed ID: 1431425
[TBL] [Abstract][Full Text] [Related]
20. Correlation between anti-C1q and immune conglutinin levels, but not between levels of antibodies to the structurally related autoantigens C1q and type II collagen in SLE or RA.
Rönnelid J; Gunnarsson I; Nilsson-Ekdahl K; Nilsson B
J Autoimmun; 1997 Aug; 10(4):415-23. PubMed ID: 9237806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
